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Abstract
Periodontal diseases are silent infections that often go undiagnosed until 
irreparable damage occurs to the teeth and oral structures. These chronic oral 
infections are characterized by the presence of a biofilm matrix that adheres to the 
periodontal structures and serves as a reservoir for bacteria (plaque). Response 
of the body toward the bacterial challenge of dental plaque can lead to bone loss 
and the migration of the junctional epithelium, resulting in periodontal pocket-
ing and periodontal disease. This bacterial insult can result in destruction of the 
periodontal tissues that precipitates a systemic inflammatory and immune response 
leading to the release of several cytokines and immunomodulatory agents, which 
may affect systemic conditions and diseases. The influence of periodontal infection 
on systemic disease and conditions documented include coronary heart disease 
(CHD) and CHD-related events such as angina, infarction, atherosclerosis, and 
other vascular conditions; stroke; diabetes mellitus; preterm labor, low birth weight 
delivery, and preeclampsia; and respiratory conditions such as chronic obstructive 
pulmonary disease. Adverse pregnancy outcomes, including preeclampsia, preterm 
delivery, and intrauterine growth restriction, and fetal demise affect a significant 
number of pregnancies and are a major source of both maternal and neonatal 
morbidity and mortality. This chapter highlights the two-way relationship between 
periodontitis and adverse pregnancy outcome.
Keywords: adverse pregnancy outcome, preterm birth, low birth weight baby, 
periodontal disease, periodontal therapy
1. Introduction
Periodontitis has prevailed in human history from the dawn of civilization 
and still is a major cause of tooth loss in adult population. The etiology of peri-
odontal disease (PD) is complex in nature, and it is a multifactorial disease, which 
is largely influenced by genetic, environmental, and microbial factors [1]. The 
periodontal disease begins at the gingiva and progress downwards and affects the 
tooth-supporting structures, i.e., periodontal ligament, cementum of the root, and 
alveolar bone. The clinical features of periodontitis are bleeding from the gums, 
pus discharge, dull gnawing pain, bad breath, mobility of teeth, pathological tooth 
migration, gingival recession, and exfoliation of teeth in severe cases.
Periodontal disease results from a complex interplay between the subgingival 
biofilm and the host immune inflammatory event, which develop in the gingival 
and periodontal tissues in response to the challenge presented by the bacteria [2]. 
The bacteria may initiate the disease, but the progression is host immune-mediated, 
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and several inflammatory cells and enzymes are released which have a detrimen-
tal effect on other cells, tissues, and organ systems. There is a shift from healthy 
nonpathogenic flora to a huge virulent and infectious anaerobic flora in the peri-
odontal disease. These bacteria and their toxins and various pro-inflammatory 
mediators penetrate into systemic circulation. The penetration of bacterial toxins 
and host-mediated immunomodulatory mediators into systemic circulation can 
have a toxic effect on the cells and organs elsewhere in the body. Environmental, 
physical, social, and host stresses may affect and modify disease expression through 
a multitude of pathways.
Systemic diseases tend to increase the periodontitis progression and can compli-
cate the treatment of periodontal diseases. Periodontal infection may significantly 
enhance the risk for certain systemic diseases or alter the natural course of systemic 
conditions. There is a two-way relationship between periodontal disease and 
systemic disease or condition in an individual. The influence of periodontal infec-
tion on systemic disease and condition documented includes coronary heart disease 
(CHD) and CHD-related events such as angina, infarction, atherosclerosis, and 
other vascular conditions; stroke; diabetes mellitus; preterm labor, low birth weight 
delivery, and preeclampsia; and respiratory conditions such as chronic obstructive 
pulmonary disease [3].
Adverse pregnancy outcomes have been attributed to infections and inflam-
matory conditions in the vagina and elsewhere in the body. The potential role of 
chronic bacterial infections elsewhere in the body remote from the fetal-placental 
unit, which may influence the health and growth of babies in the placenta, has 
been studied immensely. This realization that infection in any part of the body 
can affect the placenta has led to the idea that periodontal disease can be a pos-
sibility in adverse pregnancy outcome. Local elevation of pro-inflammatory 
prostaglandins and cytokines due to “chronic gram-negative infection” in the 
periodontal diseases can be a risk factor [4]. Periodontal diseases have shown 
to increase the systemic levels of some of these inflammatory mediators [5]. 
Periodontal disease has a possibility to influence pregnancy outcome through 
an indirect mechanism, involving inflammatory mediators or a direct bacterial 
assault on the amnion and causing preterm low birth weight babies (PLBW). This 
chapter highlights the bi-directional relationship between pregnancy, pregnancy 
outcome, and periodontal disease.
1.1 Focal infection theory revisited
William Hunter, a British physician in 1900, first developed the idea that oral 
microorganisms were responsible for a wide range of systemic conditions that were 
not easily recognized as being infectious in nature. Hunter also identified gingivitis 
and periodontitis as foci of infection and advocated the extraction of teeth with 
these conditions to eliminate source of sepsis. He also thought that oral organ-
isms had specific actions on different tissues and that these organisms were acted 
by producing toxins, thereby resulting in low-grade superinfection that produce 
systemic effect over prolonged periods. The Hunter theory became widely accepted, 
thereby leading to wholesale extraction of teeth. The focal infection theory fell into 
disrepute during the 1940s and 1950s when widespread extraction failed to reduce 
or eliminate the systemic conditions. However, Hunter ideas did encourage exten-
sive research in the areas of microbiology and immunology. The Hunter theories 
are being revived today in light of recent research demonstrating links between oral 
and systemic health. Today’s era of evidence-based medicine and dentistry provides 
an excellent environment in which to examine the possible relationship between 
oral infection and systemic disorders.
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The first association between periodontal disease and preterm low birth weight 
babies was documented by Offenbacher and colleagues in 1996 using a case-control 
study design. The study by Offenbacher et al. [6] suggested that maternal periodon-
tal disease could lead to a sevenfold increased risk of delivery of a preterm low birth 
weight infant. Human case-control studies have demonstrated that women who 
have low birth weight infants as a consequence of either preterm labor or premature 
rupture of membranes tend to have more severe periodontal disease than mothers 
with normal birth weight infants [7].
1.2 Pregnancy and its outcome
Every pregnant woman who is carrying a live baby in her womb wishes to deliver 
a healthy baby. There are numerous genetic, pathological, and environmental fac-
tors that can affect the growth and development of the baby in the womb. During 
the course of a normal pregnancy, a series of profound and dynamic physiological 
changes occur in both the mother and developing baby [8]. Pregnancy and parturi-
tion involve a complex series of molecular and biological events for mother and 
fetus. Pregnancy by itself does not cause periodontal diseases, but the hormonal 
changes during pregnancy accentuate the gingival response to plaque and modify 
resultant clinical picture.
Medical science aims at reducing the risk factors involved in the growth and 
development of a baby in the womb. Adverse pregnancy outcomes including pre-
eclampsia, preterm delivery, intrauterine growth restriction, and fetal demise affect 
a significant number of pregnancies and are a major source of both maternal and 
neonatal morbidity and mortality. The Centers for Disease Control and Prevention 
(CDC) advocates that babies born with less than 5.5 pounds or 2.5 kg will be at risk 
of long-term health problems such as delayed motor skills, social growth, or learn-
ing disabilities. Babies born, at least 3 weeks, earlier than its due date have also risk 
for retarded growth and development [9]. Respiratory problems, vision and hearing 
loss, or feeding and digestive problems are other problems associated with preterm 
and low birth weight babies.
Adverse pregnancy outcomes (APOs) are serious events that every year cause the 
death or disability of many newly born infants worldwide [10]. The most common 
adverse pregnancy outcomes are represented by low birth weight (LBW), preterm 
birth (PTB), and preeclampsia (PE). Adverse pregnancy outcomes represent an 
important health issue which affects not only the infant but also the mother, and 
more than half a million women die each year from related causes. About 10–15% of 
maternal death during pregnancy is associated with PE and eclampsia, which could 
affect the liver, kidneys, brain, and the clotting system.
World Health Organization (WHO) in 1995 defined low birth weight (LBW) 
as any live birth of <2500 g and very low birth weight to be <1500 g. WHO defines 
preterm birth as any live birth at <37 weeks of gestation period [11, 12]. More than 
33% of the infant mortality is attributed to the preterm low birth weight (PTLW), 
and surviving infants also have increased morbidity to congenital, neurological 
disabilities, and various developmental defects.
Little reduction in incidence of adverse pregnancy outcomes has occurred 
despite advances in technology, promotion of prenatal care, and continued sci-
entific efforts. Investigations to detect the potential causative factors for adverse 
pregnancy outcome include infection and/or inflammation in the reproductive tract 
and at sites remote from the feto-placental unit. The relationship between adverse 
pregnancy outcomes and maternal periodontal infections has been studied exten-
sively over the past 10 years, as periodontal infection is most prevalent in popula-
tions with highest risk of adverse pregnancy outcomes.
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1.3 Maternal immunological changes during pregnancy
Previously, it was believed that there was little or no exposure of the mother to 
the immunologically foreign cells of the fetus. It is now clarified that there is consid-
erable mixing of maternal and fetal cells, especially at the maternal-fetal interface.
One of the major alterations in the immune system during pregnancy is partial 
dampening of the mother’s cell-mediated immune responses associated with 
T-helper type 1 (Th1) lymphocytes. Stimulated Th2 cells produce an array of 
cytokines, such as interleukin-4, interleukin-5, and interleukin-10, which suppress 
cell-mediated immune responses [13–15]. The mechanisms of this partial shift in 
the Th1/Th2 balance favoring Th2-mediated immune responses are not fully under-
stood but are partly dependent on changes in progesterone, estrogen, and chorionic 
gonadotropin during pregnancy [8, 16].
Neutrophils in the peripheral circulation of pregnant women exhibit a significant 
reduction in myeloperoxidase, respiratory burst activities, and phagocytosis [8]. All of 
these inhibitory effects on neutrophils are most marked during the second and third 
trimesters [17, 18]. The postpartum readjustment of the mother’s immune system occurs 
soon after birth, with rapid re-establishment of several Th1-associated and other pro-
inflammatory host responses (Table 1). The phenomenon of return of immunological 
response after postpartum has been termed the “immune reconstitution syndrome” [15].
1.4 Gingival pyogenic granulomas in pregnancy
Pyogenic granuloma (PG) or pregnancy tumor is a non-specific inflammatory 
lesion of the skin and mucous membranes. PG occurs in both males and females 
as inflammatory lesion on skin or mucous membrane. PG occurs approximately 
0.5–2.0% of pregnant women with gingival lesions developing in interdental gingiva 
(Figure 1). They are also called pregnancy tumors or granuloma gravidarum. 
Components Changes in host response
Innate immunity
Monocytes and 
neutrophils
Effect on cellular immunity via enhanced phagocytosis and superoxide anion 
generation (respiratory burst); increased expression of CD14
Natural killer cells Effect on cellular immunity via downregulation of cytotoxic activity by 
progesterone-induced blocking factor and IL-10; decreased IFN-c production
Complement Effect on humoral immunity by increased C3, C4, and C1q levels and elevated levels 
of complement regulatory proteins including membrane cofactor protein (CD46), 
decay accelerating factor (CD55), and CD59
Acute-phase 
reactants
Effect on humoral immunity via increased levels of acute-phase reactants (e.g., 
fibrinogen and ceruloplasmin)
Adaptive immunity
T cells Effect on cellular immunity via enhanced Th2 (e.g., IL-4, IL-10) and Th3 (i.e., TGF-
b) and suppressed Th1 (IFN-c, IL12) responses
Effect on humoral immunity via increased T cell-dependent immunoglobulin 
production
B cells Effect on cellular immunity via increased Th2-induced B-cell activity
IL, interleukin; IFN, interferon; Th1, T-helper type 1 lymphocytes; Th2, T-helper 
type 2 lymphocytes; TGF, transforming growth factor
IL, interleukin; IFN, interferon; Th1, T-helper type 1 lymphocytes; Th2, T-helper type 2 lymphocytes; TGF, 
transforming growth factor.
Table 1. 
Innate and adaptive immunity changes during pregnancy [8]
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 The lesion frequently presents as a rapidly growing gingival mass that may bleed pro-
fusely when touched. Based on histological features, it is a highly proliferative vascular 
lesion resembling granulation tissue. The etiological triggers for pyogenic granuloma are 
unknown; most lesions are associated with the presence of local irritants or trauma [19].  
The pathogenesis of the lesion has been linked to female sex hormones, which stimu-
late increased local synthesis of angiogenic factors such as vascular endothelial growth 
factor and angiopoietin-2 [8]. Clinical complaints with pregnancy-associated pyogenic 
granulomas include gingival bleeding, tenderness, and esthetic problems. Treatment 
may include surgical removal, especially if the lesion is large and symptomatic [19, 20]. 
However, in many cases, the lesions undergo partial or complete resolution after 
delivery, especially if local irritants are removed [8].
1.5 Plaque-induced periodontal infections in pregnancy
Experimental gingivitis study of women during pregnancy and at 6 months 
postpartum showed that there was more gingival inflammation during pregnancy 
despite no significant differences in plaque scores. Cross-sectional studies indicate 
that 100% of women develop gingivitis between 3 and 8 months of their preg-
nancy, with a gradual decrease after parturition [21]. In some cases, the gingival 
inflammation is very severe and may be accompanied by gingival tenderness and 
profuse bleeding. Longitudinal studies have demonstrated that, during pregnancy, 
probing depths increase as the gingival inflammation increases. The increase in 
probing depths has been attributed to movement of the gingival margin in a coronal 
direction because of inflammation-induced swelling of the gingiva. Most authors 
have found that there is usually no permanent loss of clinical attachment [22, 23]. 
Individuals, especially those who have chronic periodontitis prior to becoming 
pregnant, tend to have increased rate of progression of periodontitis. Several stan-
dard cultural microbiological studies have shown that estrogen and progesterone 
changes associated with pregnancy have an effect on the composition of the subgin-
gival microbiota. Some of the periodontal pathogens that apparently blossom under 
the selective pressure of pregnancy-associated steroids are Prevotella intermedia, 
Bacteroides species, and Campylobacter rectus [8].
Diverse array of pathogens that have the potential to cause periodontal tissue 
damage have been found in pregnant and parous women through microbiologi-
cal studies using DNA probes [24, 25]. Several types of spirochetes, including 
Treponema denticola, as well as numerous gram-positive and gram-negative putative 
periodontal pathogens, are found in pregnant and nonpregnant women. Prominent 
gram-positive bacteria in this group are Streptococcus intermedius, Parvimonas micra 
Figure 1. 
A case of pyogenic granuloma in maxillary right lateral incisor region in a 9-month pregnant woman.
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(formerly Micromonas micros and Peptostreptococcus micros), Peptostreptococcus 
anaerobius, Staphylococcus aureus, and Actinomyces odontolyticus. Frequently detected 
gram-negative organisms include Porphyromonas gingivalis, Tannerella forsythia, 
C. rectus, P. intermedia, Prevotella nigrescens, Fusobacterium nucleatum, Eikenella 
corrodens, Selenomonas noxia, Enterococcus faecalis, Pseudomonas aeruginosa, 
Haemophilus influenzae, and Aggregatibacter actinomycetemcomitans. [8] As the 
immunological changes associated with pregnancy include an increased susceptibil-
ity to intracellular pathogens, it is not surprising that survival of locally invasive 
bacteria such as P. intermedia and A. actinomycetemcomitans is enhanced during 
pregnancy [8].
Gingivitis and periodontitis are plaque-induced periodontal diseases, which 
are multifactorial infections involving innate and adaptive immune responses of 
the host toward tooth-associated microbial biofilms (plaque). Pregnant women 
undergo a lot of physiological and immunological changes during pregnancy. These 
changes in pregnancy have profound effects on the host-parasite interactions found 
in microbial infections. The exact mechanisms responsible for the increased gingi-
val inflammation during pregnancy are not fully understood. It is clear that pertur-
bations in neutrophil function, modifications in cellular and humoral immunity, 
hormone-induced changes in cellular physiology, and local effects on microbial 
ecology all play crucial roles [8].
1.6 Periodontal infections and gestational diabetes mellitus
Gestational diabetes mellitus (GDM) refers to the detection of glucose intoler-
ance or raised blood glucose level, for the first time during pregnancy in a woman. 
Gestational diabetes occurs in approximately 7% of women during pregnancy, and 
it is a multifactorial disease. GDM has been associated with a long list of risk factors 
[26]. The increased blood sugar levels make the pregnant woman more susceptible 
for periodontal diseases.
Periodontitis and diabetes are both risk to each other, and studies have proved 
that increased diabetes was correlated with increased severity of periodontitis. 
Studies have been conducted on association of microorganisms and gestational 
diabetes, and contradictory results are obtained. Several study groups concluded 
that there appears to be an association between periodontal disease and gestational 
diabetes mellitus, but prospective studies with large enough sample sizes are 
required to confirm a relationship [8].
1.7 Preeclampsia in pregnant woman and periodontal infections
Preeclampsia is a condition characterized by hypertension, with blood pressure 
higher than 140/90 mmHg, and the patient also suffers from peripheral edema and 
proteinuria (i.e., urinary excretion of ±300 mg protein in 24 h) [27, 28]. Eclampsia 
occurs when there is a failure to control physiological abnormalities in a pregnant 
woman leading to convulsions, coma, and death of the mother.
Multiple factors are involved in the etiology of preeclampsia including infec-
tion, genetic susceptibility, immune responses, abnormal placentation secondary 
to hypoxia and impaired arterial remodeling, and a markedly enhanced systemic 
inflammatory burden. Increased risk of preeclampsia is seen with elevated serum 
levels of C-reactive protein; periodontal infections contribute to the increased 
C-reactive protein level [29, 30]. Therefore, it is biologically plausible that peri-
odontal infections could play a part in the multifactorial etiology of preeclampsia. 
The link between periodontal disease and risk of preeclampsia is proved only in few 
populations and has not been confirmed in all populations [8].
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1.8 Two-way relationship between periodontitis and pregnancy
Periodontal disease (PD) per se causes little clinical features and goes unnoticed 
until late in disease status. The tissue destruction is characterized by the formation 
of periodontal pocket that acts as reservoirs for bacterial colonization in the dento-
gingival environment.
Multiple factors have been associated with preterm baby (PB) and/or LBW such 
as smoking, drug use, high or low maternal age, low socioeconomic strata, inad-
equate prenatal care, low maternal body mass index (BMI), hypertension, genito-
urinary tract infections, cervical incompetence, diabetes, low nutritional status, 
stress, and multiple pregnancies [31]. However, more than 50% of the cases do not 
show the presence of these risk factors and are still affected by PB and/or LBW [15]. 
The search continues for other causes including the presence of the chronic infec-
tious diseases like periodontal infection.
The hypothesis that infection remote from the fetal-placental unit may influence 
PLBW has led to an increased awareness of the potential role of chronic bacterial 
infections elsewhere in the body. Periodontal disease is associated with a “chronic 
gram-negative infection” of the periodontal tissues which results in long-term local 
elevation of pro-inflammatory prostaglandins and cytokines [8] and an increase in 
the systemic levels of some of these inflammatory mediators [20]. Hence, peri-
odontal disease has a potential to influence PLBW through an indirect mechanism, 
involving inflammatory mediators or a direct bacterial assault on the amnion [28].
Multiple factors have been associated with the delivery of preterm and low birth 
weight infants. The evidence suggests that an infectious etiology is the main cause for a 
large percentage of cases for preterm birth. Genitourinary tract infections, such as bac-
terial vaginosis, and inflammatory mediators resulting from such infections have been 
considered a biologically plausible pathway for preterm labor and premature rupture 
of the membranes. Alternatively, it was hypothesized that preterm low birth weight 
may be indirectly mediated through distant infections resulting in translocation of 
bacterial vesicles and lipopolysaccharide (LPS) in the systemic circulation. However, 
the exact mechanisms for the proposed relationship remain unclear. The periodontal 
infection is initiated by predominantly gram-negative, anaerobic, and microaerophilic 
bacteria that colonize the subgingival area. Host defense mechanisms play integral role 
in the pathogenesis of periodontal disease. It has been postulated that the association 
between periodontal disease and preterm low birth weight (PLBW) may have similar 
pathogenic mechanisms as other maternal infections [32]. Inflamed periodontal tissues 
produce significant amounts of pro-inflammatory cytokines, mainly interleukin 1 
(IL-1b), IL-6, prostaglandin E2, and tumor necrosis factor-alpha (TNF-α), which may 
have systemic effects on the host, leading to premature rupture of membrane. Hence, 
periodontal disease has the potential to influence preterm low birth weight through an 
indirect mechanism involving inflammatory mediators or a direct bacterial assault on 
the amnion [8, 33] (Figure 2).
The inflammation and infection caused during the periodontal disease is not just 
limited to the oral cavity but also enters the systemic circulation. The systemic immune 
response gets activated due to the episodes of bacteraemia and dissemination of endo-
toxins from periodontal pockets. Systemic circulation may induce pro-inflammatory 
cytokine production due to the presence of bacteria or bacterial endotoxins in the 
systemic circulation. IL-6 and C-reactive protein that are released during chronic low-
grade inflammation are further activated due to presence of cytokines in the systemic 
circulation. The endothelial dysfunction may result due to inflammatory response of 
endothelial cells. The immune response plays a pivotal role in maintaining a healthy 
equilibrium between the mother and fetus, during pregnancy. The specific immune 
response is shifted toward a Th2-type immune response, and the inflammatory 
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response is also activated, during a normal pregnancy. During pregnancy there is an 
increase in expression of activation markers on monocytes and granulocytes, dif-
ferences in monocyte cytokine production, and increased circulating levels of pro-
inflammatory cytokines and inflammatory markers, such as C-reactive protein.
Periodontitis sites and subjects harbor specific microorganisms or groups of 
microorganisms. Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, 
Tannerella forsythia, and Treponema denticola are observed more frequently and/or 
in higher levels and proportions in periodontitis subjects, and Actinomyces genus are 
observed with periodontal health [34, 35]. Fusobacterium nucleatum, a bacterium, 
has been linked with adverse pregnancy outcomes. F. nucleatum is associated with 
periodontal infections and not observed during genital or uterine infections. The 
infection does not enter the womb through the genital tract; rather it enters the 
mother’s bloodstream making its way down from the oral cavity. The liver produces 
C-reactive protein (CRP), an acute-phase reactant in response to the inflammatory 
cytokine’s interleukin IL-6, IL-1, and tumor necrosis factor-alpha. Periodontal 
diseases are associated with raised level of circulating CRP levels and elevation of 
pro-inflammatory cytokines and prostaglandin [26, 29]. Adverse pregnancy out-
comes have been associated with increase in CRP levels. The CRP levels are raised 
in elevated immunoglobulin G induced by bacterial species found in destructive 
periodontal diseases [8].
The absence of the mother’s IgG antibody against organisms of the red complex is 
associated with an increased risk of premature birth of the baby. Mothers without a 
protective red complex IgG response coupled with a fetal IgM response to orange com-
plex microbes had the highest rate of prematurity. This evidence suggests the concept 
that prematurity in pregnant women may be due to systemic dissemination of oral 
organisms that translocate to the fetus in the absence of a protective maternal antibody 
response and trigger preterm babies. The high prevalence of elevated fetal IgM to C. 
rectus among premature infants raises the possibility that this specific maternal oral 
pathogen may serve as a primary fetal infectious agent eliciting prematurity.
1.9 Effect of periodontal therapy on pregnancy outcomes
No definitive conclusions can be arrived about periodontal disease (PD) 
treatment during pregnancy. Attempts to improve oral health in women during 
Figure 2. 
Schematic representation of role of bacterial infection in preterm labor.
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pregnancy have not reduced adverse pregnancy outcome (APO). No reduction in 
APOs was observed with standard PD therapy during pregnancy in several large 
clinical randomized controlled trials [36].
The dilemma of performing periodontal treatment during pregnancy to reduce 
the APOs has not been answered. Periodontal treatment even if undertaken dur-
ing pregnancy will not be thorough and completely eradicate the disease process, 
due to fear of bacteraemia which may cause APO. Pre-conception period is most 
appropriate time for periodontal treatment. Periodontal treatment to create a 
healthy mouth before conception may reduce the occurrence of APOs. The local and 
systemic inflammation caused by periodontal pathogens may not be controlled by 
periodontal treatment during pregnancy. Periodontal treatment before pregnancy 
(for nulliparous women) or in the period between pregnancies (for multiparous 
women) may reduce APOs [37].
There was a deep-seated bias in the medical/dental community against nonsurgi-
cal periodontal interventions during pregnancy [38]. After long-term studies and 
analysis, the medical and dental fraternity is in a general agreement that pregnant 
patients can safely undergo dental cleaning [39]. Interventions to reduce the morbid-
ity and mortality associated with preterm birth can be classified as primary, second-
ary, and tertiary. All interventions examined by existing studies on the effects of 
periodontal therapy on pregnancy outcomes can be classified as secondary interven-
tions [38]. It has been known for many years that nonsurgical periodontal therapy is 
effective in reducing the increased amount of periodontal inflammation associated 
with pregnancy [33, 40, 41]. Data clearly show that this therapy is safe and does 
not trigger an increase in adverse pregnancy outcomes. It has not been shown that 
routine nonsurgical periodontal therapy decreases the incidence of these outcomes. 
In general, women assigned to the periodontal treatment groups showed statistically 
significant improvements in their periodontal assessments.
2. Conclusion
Pregnancy in woman brings about profound changes in innate and adaptive 
immunity of the mother and fetus; these changes play a major role altering the clini-
cal course of a number of infectious diseases, including periodontal diseases. The 
severity of gingival and periodontal diseases increases during the course of normal 
pregnancy. Gingival inflammation and tissue response toward the microbial plaque 
is exaggerated during pregnancy due to the hormonal factors and is accepted by the 
scientific community. Pregnant women with previously existing periodontal disease 
will have increased destruction of the periodontal structures. The gingival changes 
observed during pregnancy return to normal limits immediately after delivery of 
the baby, if the local irritants are removed; this phenomenon is called as “immune 
reconstitution syndrome.” Gestational diabetes which occurs in certain pregnant 
women can increase the risk for periodontal diseases, and it should be well con-
trolled by treating gynecologist. Preeclampsia if not detected and treated can cause 
serious condition eclampsia leading to convulsions, coma, and death of the mother.
Large numbers of epidemiological studies suggest that periodontal infection is a 
modest risk factor for several adverse pregnancy outcomes. The studies conducted 
to link between periodontal diseases and adverse pregnancy outcomes have had 
contradictory results, as they were carried out in different sets of populations or 
with different study designs. It is better to consider periodontal disease as a risk 
factor for adverse pregnancy outcome, as thorough oral health maintenance helps 
the pregnant women attain a better oral health which is part of general health.
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by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
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Controversies in the academic community regarding the treatment of periodon-
tal problems have been eradicated. It is well accepted that oral prophylaxis and 
nonsurgical periodontal therapy can be rendered to pregnant women in the second 
trimester.
Periodontal diseases go unnoticed in the initial stages of disease process. The 
inflammatory load of periodontal disease can enter the systemic circulation and can 
be a risk factor for several host tissues and physiological activities. There is definite 
link between periodontal diseases and adverse pregnancy outcomes, through 
direct or indirect mechanisms. The direct action of perio-pathogenic organisms on 
amnion and indirect action through systemic circulation by production of inflam-
matory mediators can be risk for adverse pregnancy outcomes.
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